Deltex was established in 1997 as a medical technology company, to develop technologies to measure blood flow. With the successful development of the world’s first Oesophageal Doppler and subsequent research and development, Deltex produced a range of advanced Oesophageal Doppler monitors. Following a period of research and development, with the goal of improving patient outcome, Deltex launched its flagship product, CardioQ-ODM in 2010.
